ERBB2 and breast cancer: The correlations between the expression of the 8 miRNAs and the following breast cancer clinicopathological markers were computed: estrogen and progesterone receptor expression, HER2 overexpression, tumor size, initial lymph node status, Ki67 index, Scarff-Bloom-Richardson grade and lymphovascular invasion.